MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CYTK
  4. News
CYTK
Quote
Short
News
Articles
Message Board

Cytokinetics Incorporated (NASDAQ : CYTK ) News

Cytokinetics Incorporated (NASDAQ: CYTK) News Releases

CYTK News Releases
CYTK : NASDAQ
GlobeNewswire
Cytokinetics to Participate in March Investor Conferences
CYTK : NASDAQ
SeekingAlpha
Cytokinetics aims for over 50% new patient share for MYQORZO by end of 2026 as global commercial launch accelerates
CYTK : NASDAQ
SeekingAlpha
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call Transcript
CYTK : NASDAQ
Motley Fool
Cytokinetics (CYTK) Q4 2025 Earnings Transcript
CYTK : NASDAQ
SeekingAlpha
Cytokinetics GAAP EPS of -$1.50 misses by $0.05, revenue of $17.75M beats by $9.73M
CYTK : NASDAQ
GlobeNewswire
Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update
CYTK : NASDAQ
US Earnings Reports
Expected US Company Earnings on Tuesday, February 24th, 2026
CYTK : NASDAQ
SeekingAlpha
Bristol-Myers Squibb: Oncology Franchise Remains A Core Strength
CYTK : NASDAQ
GlobeNewswire
Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
CYTK : NASDAQ
GlobeNewswire
Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.